Products

One product, multiple test modalities

Select the Product most Suited to your Patient’s Symptoms

The Peerbridge Cor has two product extensions CorEvent and CorXT, with the CorHRV scheduled for launch in 2019. Each share the following services and benefits:

  • Improved patient compliance due to its exercise-friendly, showerproof, comfortable design
  • Qualified Holter capability
  • Summarized, fully quantitative reporting
  • Machine learning rhythm and beat analysis algorithm

CorEvent

The CorEvent combines the benefit of event monitoring with comprehensive quantitative long-term Holter monitoring. It has three leads, providing 2 channels of clean ECG.

Other services and benefits are:

  • Full quantitative seven-day arrhythmia analysis including a comprehensive report with chapters that detail:
    • Minute by minute heart rate
    • AFIB/AFL burden
    • Ventricular and Supraventricular ectopy
    • Pause/conduction defects

 

  • Continuous full disclosure ECG reporting
  • Symptomatic patient activated events
  • Asymptomatic events captured in full retrospective analysis
  • Cloud-based arrhythmia analysis algorithm detects 20+ rhythm statements
  • End of study event summary report

Compare CorEvent with traditional Event Monitor

Current Event Monitoring

Peerbridge Cor Event

No quantitative rhythm analysis provided Full quantitative 7-day arrhythmia analysis includes a comprehensive report with chapters detailing: Heart Rate, Atrial Fibrillation burden, HRV, with daily rate analysis, Ventricular and Supraventicular ectopy and Pause/Conduction defects
Daily self application by patient potentially impacts ECG quality In-office prep/application by clinicians yields better ECG quality
Intermittent wear, remove to shower, limited patient compliance. Average daily wear time 16 hours/day Continuous wear, shower friendly, improved patient compliance. Average daily wear time 24 hrs/day
Intermittent loop ECG recording Continuous full disclosure ECG recording
Symptomatic patient-triggered events: 90 sec. Symptomatic patient-activated events: 120 sec.
Asymptomatic auto-triggered events: 90 sec. Detects: programmed Tachy, Brady, Pause and AFIB. (often resulting in false positives) Asymptomatic events captured in full retrospective analysis
Onboard limited analysis algorithm detects 4 rhythms at specific programmed parameters Cloud-based arrhythmia analysis algorithm detects 26 rhythm statements
End of study event summary report End of study event summary report

CorXT

The CorXT combines the benefit of long term Holter monitoring with real time events posted to the portal throughout the study period. It has three leads, providing 2 channels of clean ECG.

Other services and benefits are:

  • Cloud-based arrhythmia analysis algorithm detects 26 rhythm statements
  • Reports one-minute heart rate resolution
  • Includes spectral and time domain HRV analysis
  • Patient activated events captured through the sensor are detailed electronically by the handheld transmitter
  • Patient events transmitted and posted to the Peerbridge portal are available throughout the monitoring session
  • Retrospective analysis and report available after the device is returned
  • Multi-lead patch provides modified Lead 2 and Lead 3

Compare CorXT with traditional long term Holter patch

Current continuous Long Term Recording patch

Peerbridge Cor XT

Reports <10 quantitative rhythms Reports >26 quantitative rhythms
Reports 15-20 minute Heart Rate resolution Reports 1 minute Heart Rate resolution
No HRV analysis Includes Spectral and Time Domain HRV analysis
Patient-triggered events (90 sec) on wearable accompanied with written patient journal (must be returned with device and manually transcribed prior to analysis) Patient-activated events (120 sec) on wearable with prompted electronic patient journal details Symptoms and Activity (6 default plus custom option available)
Patient events available with retrospective analysis which may not be available for up to 14-21 days Patient events transmitted and posted to the Portal are available throughout the monitoring session
Retrospective analysis and report available after device returned Retrospective analysis and report available after device returned
Single lead patch provides modified Lead 2. Multi-lead patch provides modified Lead 2 and 3.
Optional derived 6 lead ECG.
Up to 14-day continuous recording Up to 7-day continuous recording
Ambulatory ECG monitoring beyond 7 days often provides only an additional 3.9% of patients with a diagnosis.”12

CorHRV

More details about the Peerbridge CorHRV will be available soon.